Topics

Silencing Novel Target Genes: A New Strategy for Lipid Lowering

13:23 EST 19 Nov 2019 | Medscape

Following in the footsteps of inclisiran, two lipid-lowering therapies based on silencing specific genes involved in lipid metabolism showed promising preliminary results in initial clinical trials.
Medscape Medical News

Original Article: Silencing Novel Target Genes: A New Strategy for Lipid Lowering

NEXT ARTICLE

More From BioPortfolio on "Silencing Novel Target Genes: A New Strategy for Lipid Lowering"

Quick Search

Relevant Topic

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...